NCT02199899 Safety, Tolerability and Pharmacodynamics of BIIF 1149 BS in Healthy Young Male Volunteers Status COMPLETED Phase PHASE1
NCT02199886 Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection Status TERMINATED Phase PHASE1
NCT02199873 Safety, Tolerability and Pharmacodynamics of BIIX 1 XX in Healthy Young Male Volunteers Status COMPLETED Phase PHASE1
NCT02199860 Single Rising Dose Study Investigating the Safety, Tolerability and Pharmacokinetics of Spray Dried BIBN 4096 BS After Inhalation Administration in Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT02199847 Evaluation of the Effects of Pharmaton Tablets on Mental Performance and Physical Fatigue in Nurses Working Night Shift Status COMPLETED Phase PHASE2
NCT02198352 Study to Determine Tolerability After Intravenous Administration of BIBN 4096 BS in Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT02198339 Efficacy, Safety, Tolerability and Pharmacokinetics of BIBN 4096 BS Versus Placebo in the Treatment of a Single Attack of Acute Migraine Headache Status COMPLETED Phase PHASE2
NCT02198326 Single Rising Dose Tolerability Study of BIBN 4096 BS in Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT02198313 A Multiple Increasing Dose Safety and Tolerability Study After Inhalation Administration of BIIX 1 XX in Healthy Male Volunteers Status TERMINATED Phase PHASE1
NCT02198287 Dose Extension Study of BIIX 1 XX in Healthy Young Male Volunteers Status COMPLETED Phase PHASE1
NCT02198274 Intravenous BIBH 1 in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT02197416 Safety of Dabigatran Etexilate in Blood Clot Prevention in Children Status COMPLETED Phase PHASE3
NCT02197078 Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin Status COMPLETED Phase N/A
NCT02197026 Effectiveness and Safety of Synvisc® Versus Usual Treatments in Patients With Knee Osteoarthritis Status COMPLETED Phase PHASE4
NCT02195804 Bioavailability Study of Ranitidine Hydrochloride (Maximum Strength ZANTAC 150®) Compared to Two Different 150 mg Ranitidine Hydrochloride Oral Disintegrating Tablet (ODT) in Fasting, Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02195557 Retrospective Follow-up Study of Synvisc® in Patients With Knee Osteoarthritis Status COMPLETED Phase N/A
NCT02195505 Use of Synvisc® in Knee Osteoarthritis - Medico-economical Study Status COMPLETED Phase N/A
NCT02195492 Retrospective Follow-up of Synvisc® in Active Patients With Knee Osteoarthritis Status COMPLETED Phase N/A